Table 4.
Characteristics of patients who underwent major hepatectomy, stratified by eICG15.
| eICG15 ≤ 20.0 | eICG15 > 20.0 | p value | |
|---|---|---|---|
| Total number | 761 (89.7%) | 87 (10.3%) | |
| Age | 55.7 ± 11.7 | 58.7 ± 10.6 | <0.001 |
| Gender M/F (% M) | 615/146 (80.8%) | 75/12 (86.2%) | 0.22 |
| Bilirubin (µmol/L) | 10.9 ± 4.49 | 20.9 ± 12.2 | <0.001 |
| Albumin (g/L) | 41.2 ± 3.95 | 34.1 ± 4.40 | <0.001 |
| Prothrombin time (sec) | 12.1 ± 1.16 | 13.3 ± 2.44 | <0.001 |
| Platelet (×109/L) | 209 ± 81 | 175 ± 67 | <0.001 |
| Child-Pugh score | <0.001 | ||
| 5 | 678 (89.1%) | 25 (28.7%) | |
| 6 | 73 (9.6%) | 45 (51.7%) | |
| 7 | 10 (1.3%) | 15 (17.2%) | |
| 8 | 0 (0.0%) | 1 (1.1%) | |
| 9 | 0 (0.0%) | 1 (1.1%) | |
| ICG15 (%) | 10.7 ± 5.59 | 15.0 ± 7.33 | <0.001 |
| Tumour size (cm) | 6.97 ± 3.72 | 8.23 ± 4.42 | 0.13 |
| Portal venous invasion | 42 (5.3%) | 10 (1.5%) | 0.04 |
| Posthepatectomy liver failure | 31 (4.1%) | 7 (8.0%) | 0.09 |
| In-hospital mortality | 28 (3.7%) | 7 (8.0%) | 0.052 |
| Median overall survival (year) | 5.10 ± 0.553 | 3.01 ± 0.878 | 0.015 |
| Median disease free survival (year) | 1.37 ± 0.215 | 0.707 ± 0.183 | 0.018 |